Data / New clinical trials / Liver Cirrhosis

Liver Cirrhosis trials: 200 new since Nov 2024

Name: New Liver Cirrhosis clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Liver Cirrhosis clinical trials: 200 rows for $10, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 9 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/liver-cirrhosis, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

200 clinical studies in Liver Cirrhosis were first posted on ClinicalTrials.gov from November 19, 2024 to November 6, 2026; 18 have an industry sponsor and 140 are recruiting or about to. The newest, NCT07923318, was posted on November 6, 2026: Optimal Treatment Strategy for Spontaneous Bacterial Peritonitis (Chonnam National University Hospital).

The request: Every new Liver Cirrhosis clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

200New trials
18Industry sponsored
140Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 200, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07923318	Optimal Treatment Strategy for Spontaneous Bacterial Peritonitis	Chonnam National University Hospital	Not applicable	Recruiting	Spontaneous Bacterial Peritonitis, Paracentesis, Treatment Efficacy, Adverse Events, Survival Rate	40	South Korea	clinicaltrials.gov
November 6, 2026	NCT07920744	The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated Cirrhosis	Fifth Affiliated Hospital, Sun Yat-Sen University	Observational	Recruiting	Liver Cirrhosis, Gastroesophageal Varices	364	China	clinicaltrials.gov
October 29, 2026	NCT07903103	Prickly Pear Pulp Powder Along With an Anti-inflammatory Diet in Patients Having Liver Fibrosis	University of Lahore	Not applicable	Not yet recruiting	Lipid Profile, Blood Glucose, Liver Enzymes	120	Pakistan	clinicaltrials.gov
October 28, 2026	NCT07901556	Effect of Mini-Program Monitoring on Hepatic Encephalopathy in Post-TIPS Patients	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Not applicable	Not yet recruiting	Hepatic Encephalopathy, Liver Cirrhosis	394		clinicaltrials.gov
October 21, 2026	NCT07885969	Safety of Anticoagulation Therapy in Cirrhotic Patients With PVT and Severe Thrombocytopenia	Qilu Hospital of Shandong University	Observational	Completed	Thrombocytopenia Related to Chronic Liver Disease, Anticoagulation Treatment, Safety, Portal Vein Thrombosis	304	China	clinicaltrials.gov
October 21, 2026	NCT07885007	AI-SC Multi-center Study	University Health Network, Toronto	Observational	Active not recruiting	Liver Cirrhosis	1,000	Canada	clinicaltrials.gov
October 16, 2026	NCT07877298	Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement	University Hospital Muenster	Observational	Not yet recruiting	Portal Hypertension, Chronic Liver Disease, Liver Cirrhosis	150	Belgium, Canada, Germany, Italy	clinicaltrials.gov
October 16, 2026	NCT07877272	Endohepatology-Based Reclassification of Treatment Indication in High-Risk MASLD	University Hospital Muenster	Observational	Recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, Liver...	500	Germany	clinicaltrials.gov
October 14, 2026	NCT07874204	Equivalence of Electronic vs Paper-based PHES in Diagnosing Hepatic Encephalopathy	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Not applicable	Not yet recruiting	Liver Cirrhosis, Hepatic Encephalopathy (HE), Minimal Hepatic Encephalopathy	80		clinicaltrials.gov
October 6, 2026	NCT07861594	Lifestyle, Dietary Patterns, and Cardiometabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Among People Living With...	Assiut University	Observational	Not yet recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), HIV Infections, Non-Alcoholic Fatty Liver Disease...	250		clinicaltrials.gov
October 2, 2026	NCT07854782	Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)	Regeneron Pharmaceuticals	Phase 3	Recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD	1,500	United States	clinicaltrials.gov
October 1, 2026	NCT07852416	Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy	The First Affiliated Hospital with Nanjing Medical University	Not applicable	Not yet recruiting	Liver Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy	80	China	clinicaltrials.gov
September 28, 2026	NCT07843446	Residual Histological Disease Across Treatment Pathways in Chronic Hepatitis B	Istanbul Medeniyet University	Observational	Completed	Chronic Hepatitis B	1,201	Turkey (Türkiye)	clinicaltrials.gov
September 22, 2026	NCT07834905	Nutritional Indices and Inflammatory Markers in MASLD	Assiut University	Observational	Not yet recruiting	Liver Fibrosis, Malnutrition, Non-Alcoholic Fatty Liver Disease	180		clinicaltrials.gov
September 21, 2026	NCT07830303	Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis	Wang Fengmei	Phase 4	Not yet recruiting	Liver Cirrhosis, Sleep Disturbance, Hepatic Encephalopathy	180	China	clinicaltrials.gov
September 18, 2026	NCT07827430	Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD	Assiut University	Observational	Not yet recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease, Hypothyroidism, Liver...	120		clinicaltrials.gov
September 10, 2026	NCT07811713	Effect of LSD on Renal Function in Cirrhotic Patients With Portal Hypertension	Northern Jiangsu People's Hospital	Observational	Completed	Cirrhosis, Liver, Splenectomy; Status, Renal Function Abnormal, Portal Hypertension	496		clinicaltrials.gov
September 10, 2026	NCT07811700	Effect of LSD on Lipid Profiles Within 1 Year Postoperatively in Cirrhosis Patients With Portal Hypertension Bleeding	Northern Jiangsu People's Hospital	Observational	Completed	Lipid Profiles, Cirrhosis, Liver, Portal Hypertension, Splenectomy; Status	150	China	clinicaltrials.gov
September 10, 2026	NCT07811687	Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function	Northern Jiangsu People's Hospital	Observational	Recruiting	Liver Cirrhosis, HCC - Hepatocellular Carcinoma, Hypersplenism	30	China	clinicaltrials.gov
September 2, 2026	NCT07799948	Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS	Air Force Military Medical University, China	Not applicable	Recruiting	Hepatic Encephalopathy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Portal Hypertension, Liver Cirrhosis	30	China	clinicaltrials.gov
September 1, 2026	NCT07797673	Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia	Dr Cipto Mangunkusumo General Hospital	Phase 1	Recruiting	Biliary Atresia, Kasai Operation, Liver Fibrosis, Stem Cell, Liver Function Failure	40	Indonesia	clinicaltrials.gov
August 28, 2026	NCT07793279	Hypothyroidism and Liver Fibrosis Severity in MASLD	Assiut University	Observational	Not yet recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Hypothyroidism, Liver Cirrhosis, Non-Alcoholic Fatty Liver...	85		clinicaltrials.gov
August 28, 2026	NCT07791940	Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver Cirrhosis	Fayoum University Hospital	Phase 4	Completed	Thrombocytopenia Related to Chronic Liver Disease	200	Egypt	clinicaltrials.gov
August 20, 2026	NCT07777705	Application of Different Scores in Predicting Outcomes of Cirrhotic Patients Awaiting Liver Transplantation	Assiut University	Observational	Not yet recruiting	Liver Cirrhosis, Liver Transplant	153		clinicaltrials.gov
August 14, 2026	NCT07764835	Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)	D'Or Institute for Research and Education	Observational	Not yet recruiting	Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Hepatitis B, Metabolic Dysfunction-Associated Steatotic Liver...	300		clinicaltrials.gov
August 10, 2026	NCT07755059	Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis	Massachusetts General Hospital	Not applicable	Not yet recruiting	Ascites, Liver Cirrhosis, Hypertension, Portal	60	United States	clinicaltrials.gov
August 10, 2026	NCT07754617	Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis	Rhode Island Hospital	Phase 2/3	Not yet recruiting	Schistosomiasis, Schistosoma Mansoni, Liver Fibrosis, Portal Hypertension	600	Uganda	clinicaltrials.gov
August 6, 2026	NCT07750587	Predicting Response and Exposure Changes in Cirrhosis for Effectiveness	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Not applicable	Not yet recruiting	Liver Cirrhosis	45		clinicaltrials.gov
July 29, 2026	NCT07734896	Evaluating Novel Scoring Systems to Predict Outcomes in Acute-on-Chronic Liver Failure	Assiut University	Observational	Not yet recruiting	Acute-on-Chronic Liver Failure (ACLF), Liver Cirrhosis, End Stage Liver Disease	100		clinicaltrials.gov
July 28, 2026	NCT07730853	Isocaloric Navy-Bean Substitution in Adults With MASLD	Icahn School of Medicine at Mount Sinai	Not applicable	Not yet recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Liver Fibrosis, Metabolic Dysfunction-Associated...	40	United States	clinicaltrials.gov
July 28, 2026	NCT07730736	Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome Types	Foshan Hospital of Traditional Chinese Medicine	Observational	Completed	Chronic Hepatitis B, Metabolic Associated Fatty Liver Disease	1,000	China	clinicaltrials.gov
July 27, 2026	NCT07727187	Hepatitis B Infection Surveillance	Assistance Publique - Hôpitaux de Paris	Observational	Not yet recruiting	Chronic Hepatitis B Infection	1,360	France	clinicaltrials.gov
July 24, 2026	NCT07726693	Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial	University College, London	Phase 3	Not yet recruiting	Liver Cirrhosis	1,142		clinicaltrials.gov
July 21, 2026	NCT07716384	Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness	Second Affiliated Hospital of Xi'an Jiaotong University	Observational	Not yet recruiting	Liver Fibrosis, Liver Cirrhosis, NAFLD (Nonalcoholic Fatty Liver Disease), HEPATITIS B CHRONIC	150		clinicaltrials.gov
July 20, 2026	NCT07714941	EUS-Guided ATI and SWE in Individuals With Normal FibroScan	Asian Institute of Gastroenterology, India	Observational	Not yet recruiting	Non-hepatobiliary Indications	100	India	clinicaltrials.gov
July 15, 2026	NCT07705074	FAPI PET Imaging - An Exploratory Study	Martin Huellner	Phase 1/2	Not yet recruiting	Thyroid Pathology, Head and Neck Cancer (H&N), Sinonasal Tract Tumor, Sarcoidosis, Thyroid Cancer, Breast Cancer...	770	Switzerland	clinicaltrials.gov
July 14, 2026	NCT07701031	Assessing EUS and Percutaneous Untargeted Liver Biopsy Quality	University Hospital Muenster	Observational	Completed	Liver Cirrhosis, Liver Disease Chronic, Liver Transplant	146	Germany	clinicaltrials.gov
July 2, 2026	NCT07681089	A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia	Kiminori Kimura, MD	Phase 2	Recruiting	Liver Cirrhosis	7	Japan	clinicaltrials.gov
June 30, 2026	NCT07675525	Deep Learning for Liver Fibrosis Triage in MASLD Using Longitudinal Electronic Health Records	Siriraj Hospital	Observational	Completed	MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)	1,351	Thailand	clinicaltrials.gov
June 23, 2026	NCT07663682	Correlation Between Serum Nociceptin and Sympathetic Nerve Activity in Diabetic Patients With MAFLD	Second Hospital of Shanxi Medical University	Observational	Completed	Diabetes Mellitus, Type 2, Metabolic Associated Fatty Liver Disease	100	China	clinicaltrials.gov
June 22, 2026	NCT07658794	Intraoperative Assessment of Microcirculatory Function Using Vascular Occlusion Test During Liver Transplantation	Ippokrateio General Hospital of Thessaloniki	Observational	Not yet recruiting	Liver Cirrhosis, Early Allograft Dysfunction	50	Greece	clinicaltrials.gov
June 22, 2026	NCT07658755	Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme	Hospital General Universitario Gregorio Marañon	Observational	Recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis, Non-alcoholic Fatty Liver Disease NAFLD, Type...	3,000	Spain	clinicaltrials.gov
June 18, 2026	NCT07656428	Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized Patients	National Taiwan University Hospital	Observational	Active not recruiting	Heart Failure, Congestive, Renal Failure Acute Chronic, Liver Cirrhosis, Sepsis, Edema, Pulmonary, Establish a...	9,000	Taiwan	clinicaltrials.gov
June 9, 2026	NCT07637539	Elastography-based Brief Alcohol Intervention in Hospitalized Individuals	Oslo University Hospital	Not applicable	Recruiting	Alcoholic Liver Disease (ALD), Alcohol Use Disorder	500	Norway	clinicaltrials.gov
June 8, 2026	NCT07631637	Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)	Regeneron Pharmaceuticals	Phase 2	Recruiting	Metabolic Dysfunction-Associated Steatohepatitis, MASH	360	Puerto Rico, United Kingdom, United States	clinicaltrials.gov
June 5, 2026	NCT07629128	Patients With Primary Biliary Cholangitis(PBC)	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Active not recruiting	Primary Biliary Cholangitis, Liver Fibrosis, Cirrhosis, Liver, Blood Sugar; High	30	Italy	clinicaltrials.gov
June 4, 2026	NCT07625085	The Effect of a Personalized Protein- and Energy-optimized Diet on Muscle Strength in Adult Patients With Chronic Liver Disease	University of Roma La Sapienza	Not applicable	Completed	Liver Cirrhosis	70	Italy	clinicaltrials.gov
May 29, 2026	NCT07613827	Interventional AI-Human Collaboration for Steatotic Liver Disease Screening	Shengjing Hospital	Not applicable	Enrolling by invitation	Steatotic Liver Disease, Liver Fibrosis Progression in Chronic Liver Disease, Liver Steatosis, Liver Fibrosis...	7,969	China	clinicaltrials.gov
May 29, 2026	NCT07612670	A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy	The First Affiliated Hospital with Nanjing Medical University	Observational	Not yet recruiting	Hepatic Encephalopathy, Minimal Hepatic Encephalopathy, Liver Cirrhosis	700	China	clinicaltrials.gov
May 28, 2026	NCT07612163	Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Observational	Recruiting	Bacterial Infections	1,000	China	clinicaltrials.gov
May 28, 2026	NCT07610837	Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis	AstraZeneca	Phase 2	Recruiting	Liver Fibrosis, Hepatic Cirrhosis	104	Puerto Rico, United States	clinicaltrials.gov
May 20, 2026	NCT07598669	Austrian PBC Registry	Medical University of Vienna	Observational	Recruiting	Primary Biliary Cholangitis, Liver Cirrhosis, Portal Hypertension	500	Austria	clinicaltrials.gov
May 18, 2026	NCT07592962	Whole-life Investigation of Lishui Longevity	The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital	Observational	Recruiting	Ischemic Stroke, Chronic Disease, Cardiovascular	4,500	China	clinicaltrials.gov
May 15, 2026	NCT07590284	Sonazoid CEUS for Early HCC Surveillance	Tianjin Third Central Hospital	Not applicable	Not yet recruiting	Liver Cirrhosis, Liver Fibrosis	556	China	clinicaltrials.gov
May 15, 2026	NCT07588854	Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Observational	Recruiting	Chronic Liver Disease (CLD), Liver Fibrosis	65	China	clinicaltrials.gov
May 14, 2026	NCT07588334	Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)	Northern Jiangsu People's Hospital	Observational	Not yet recruiting	Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles	30	China	clinicaltrials.gov
May 14, 2026	NCT07587671	Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis	West China Hospital	Not applicable	Not yet recruiting	Liver Cirrhosis, Portal Hypertension, Gastroesophageal Varices Bleeding, Esophageal Varices, Hepatic Encephalopathy	240	China	clinicaltrials.gov
May 14, 2026	NCT07585890	Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe	University Medical Center Groningen	Observational	Recruiting	End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation	10,000	Austria, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden...	clinicaltrials.gov
May 14, 2026	NCT07585786	Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)	Northern Jiangsu People's Hospital	Observational	Not yet recruiting	Cirrhosis, Liver, Splenectomy; Status, Renal Function Abnormal, Portal Hypertension	30		clinicaltrials.gov
May 6, 2026	NCT07571876	Ultrasound Prediction of Esophageal Variceal Bleeding Risk	Assiut University	Observational	Not yet recruiting	Variceal Bleeding, Ultrasonography, Esophageal Bleeding, Esophageal Varices, Liver Cirrhosis, Portal Hypertension...	165		clinicaltrials.gov
May 6, 2026	NCT07571460	Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis	Kafrelsheikh University	Phase 4	Completed	Liver Cirrhosis, Portal Vein Thrombosis	21	Egypt	clinicaltrials.gov
May 1, 2026	NCT07561138	Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation	Kalliopi Anna Poulia	Not applicable	Recruiting	End-stage Liver Disease, Liver Cirrhosis, Liver Transplantation, Malnutrition, Sarcopenia, Frailty	90	Greece	clinicaltrials.gov
May 1, 2026	NCT07560202	Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and Predictors	Elham Ahmed Hassan	Observational	Active not recruiting	Liver Cirrhosis, Portal Vein Thrombosis	240	Egypt	clinicaltrials.gov
April 28, 2026	NCT07553858	Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy	Rutgers, The State University of New Jersey	Not applicable	Not yet recruiting	Hepatic Encephalopathy, Liver Cirrhosis, Portal Shunt Systemic	34	United States	clinicaltrials.gov
April 22, 2026	NCT07544121	Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis...	Nanfang Hospital, Southern Medical University	Not applicable	Not yet recruiting	HEPATITIS B CHRONIC, Cirrhosis, Liver, Hepatocellular Carcinoma (HCC)	1,034		clinicaltrials.gov
April 17, 2026	NCT07537829	Risk Factors and Prediction Model for Liver-Related Outcomes in Elderly Patients With Steatotic Liver Disease	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Observational	Completed	Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease	10,000	China	clinicaltrials.gov
April 15, 2026	NCT07530419	Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)	Seoul National University Hospital	Observational	Active not recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Fatty Liver, Liver Fibrosis	95	South Korea	clinicaltrials.gov
April 14, 2026	NCT07529262	Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial	Curtin University	Phase 3	Not yet recruiting	Liver Cirrhosis	890		clinicaltrials.gov
April 7, 2026	NCT07513922	The Correlation Between hs CRP TG Triglycerides Glucose Index in NAFLD and Liver Fibrosis	Assiut University	Observational	Not yet recruiting	Liver Fibrosis	96	Egypt	clinicaltrials.gov
March 30, 2026	NCT07502196	Heart Problems in Children With Chronic Liver Disease	Assiut University	Observational	Not yet recruiting	Chronic Liver Disease (CLD), Liver Cirrhosis, Cardiac Abnormalities, Portopulmonary Hypertension, Cirrhotic...	60		clinicaltrials.gov
March 27, 2026	NCT07495332	Siemens Biomarker Multi-modality	Duke University	Not applicable	Recruiting	Fatty Liver, Hepatic Steatosis	45	United States	clinicaltrials.gov
March 25, 2026	NCT07492862	Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Not applicable	Not yet recruiting	Porto-sinusoidal Vascular Liver Disorder, Liver Cirrhosis, Portal Hypertension, Noncirrhotic, Portal Hypertension...	100	Italy	clinicaltrials.gov
March 24, 2026	NCT07490405	Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism	Northern Jiangsu People's Hospital	Observational	Not yet recruiting	Liver Cirrhosis	140	China	clinicaltrials.gov
March 18, 2026	NCT07481032	Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis...	Nanfang Hospital, Southern Medical University	Not applicable	Not yet recruiting	Cirrhosis, Liver, Hepatocellular Carcinoma (HCC), HEPATITIS B CHRONIC	1,034		clinicaltrials.gov
March 18, 2026	NCT07480096	Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems	Universitas Indonesia	Phase 2	Completed	Cirrhosis, Liver Cirrhosis, Sleep Quality, Insomnia, Hepatic Encephalopathy	82	Indonesia	clinicaltrials.gov
March 17, 2026	NCT07475962	Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes	Institut de Recherches Cliniques de Montreal	Observational	Not yet recruiting	Type 1 Diabetes, Liver Steatoses, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis...	100		clinicaltrials.gov
March 16, 2026	NCT07472270	Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment	Vinmec Research Institute of Stem Cell and Gene Technology	Phase 1	Not yet recruiting	Liver Cirrhosis	12	Vietnam	clinicaltrials.gov
March 13, 2026	NCT07470515	Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study	Medical University Innsbruck	Not applicable	Not yet recruiting	Liver Cirrhosis, Refractory Ascites, Variceal Bleeding, Portal Hypertension	30	Austria	clinicaltrials.gov
March 12, 2026	NCT07465471	Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis.	Institute of Liver and Biliary Sciences, India	Not applicable	Not yet recruiting	Liver Cirrhosis	210	India	clinicaltrials.gov
March 10, 2026	NCT07459972	Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis	Kafrelsheikh University	Phase 4	Completed	Liver Cirrhosis, Portal Hypertension Related to Cirrhosis	22	Egypt	clinicaltrials.gov
February 27, 2026	NCT07439939	Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement	Assistance Publique - Hôpitaux de Paris	Observational	Recruiting	Liver Cirrhosis, Portal Hypertension	45	France	clinicaltrials.gov
February 27, 2026	NCT07439536	Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis	Kafrelsheikh University	Phase 4	Completed	Liver Cirrhosis With Diabetes	64	Egypt	clinicaltrials.gov
February 27, 2026	NCT07437638	Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis	The Second Affiliated Hospital of Chongqing Medical University	Observational	Active not recruiting	Liver Cirrhosis, Hepatic Encephalopathy, TIPS	624	China	clinicaltrials.gov
February 25, 2026	NCT07433881	Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis	Institute of Liver and Biliary Sciences, India	Observational	Not yet recruiting	Liver Cirrhosis	360	India	clinicaltrials.gov
February 24, 2026	NCT07429864	Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Recruiting	HBV, HBV Coinfection, HCV, HIV Infections, Hepatocellular Carcinoma, Cirrhosis, Liver, Fibrosis, Liver, Bile Acid...	20	Italy	clinicaltrials.gov
February 20, 2026	NCT07424963	Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)	Military University Hospital, Prague	Not applicable	Recruiting	Cirrhosis, Portal Hypertension, EUS, Non-Cirrhotic Portal Hypertension, HVPG, Hepatic Venous Pressure Gradient	40	Czechia	clinicaltrials.gov
February 20, 2026	NCT07422701	Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation	Peking University First Hospital	Observational	Not yet recruiting	Portal Vein Thrombosis, Liver Cirrhosis	2,522	China	clinicaltrials.gov
February 18, 2026	NCT07418008	The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)	University of Malaya	Observational	Recruiting	Liver Cirrhosis, Cognitive Dysfunction, Hepatic Encephalopathy, Neurocognitive Disorders	230	India	clinicaltrials.gov
February 17, 2026	NCT07412236	A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic...	Beijing Continent Pharmaceutical Co, Ltd.	Phase 3	Not yet recruiting	Liver Fibrosis, Liver Fibrosis in Chronic Hepatitis B	1,208	China	clinicaltrials.gov
February 12, 2026	NCT07405749	Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Not yet recruiting	Cirrhosis, Liver, Portal Hypertension, Clinically Significant Portal Hypertension(CSPH), Gastroesophageal Varices	2,500	Italy	clinicaltrials.gov
February 10, 2026	NCT07400367	Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With...	Fu Jen Catholic University Hospital	Not applicable	Recruiting	Liver Elastography, Liver Steatosis, Liver Function Test, Insulin Resistance, Cardiometabolic Risk Factors	80	Taiwan	clinicaltrials.gov
February 9, 2026	NCT07397481	Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients	Kafrelsheikh University	Phase 4	Completed	Liver Cirrhosis, Arterial Hypertension	40	Egypt	clinicaltrials.gov
February 6, 2026	NCT07394309	Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls	Beijing Continent Pharmaceutical Co, Ltd.	Phase 1	Completed	Liver Fibrosis	30	China	clinicaltrials.gov
January 29, 2026	NCT07376967	Improving Healthcare Outcomes With Early Detection of Liver Related Complications in Liver Cirrhosis Patients by Implementing a...	Maastricht University	Not applicable	Completed	Liver Cirrhosis	50	Netherlands	clinicaltrials.gov
January 28, 2026	NCT07374185	Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis	Global Stem Cell Center, Baghdad	Not applicable	Recruiting	Liver Cirrhosis	10	Iraq	clinicaltrials.gov
January 22, 2026	NCT07359742	Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers	Universitair Ziekenhuis Brussel	Not applicable	Recruiting	Chronic Liver Disease (CLD), Fibrosis of Liver	110	Belgium	clinicaltrials.gov
January 20, 2026	NCT07350070	TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension	Tongji Hospital	Phase 2	Not yet recruiting	HCC, Liver Cirrhosis, Portal Hypertension	78	China	clinicaltrials.gov
January 20, 2026	NCT07349654	Underdilated-stent Technique Improves Post-TIPS Encephalopathy	The Second Affiliated Hospital of Chongqing Medical University	Not applicable	Recruiting	Liver Cirrhosis, Variceal Bleeding, Cirrhosis, Ascites Hepatic, Hepatic Encephalopathy (HE)	72	China	clinicaltrials.gov
January 16, 2026	NCT07347275	A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.	Yaqrit Ltd	Not applicable	Recruiting	Acute-on-Chronic Liver Failure (ACLF), Liver Cirrhosis	72	United Kingdom	clinicaltrials.gov
January 15, 2026	NCT07343037	Diagnosis of Lymphohistiocytic Hemophagocytosis in Intensive Care	University Hospital, Strasbourg, France	Observational	Recruiting	Hepatic Insufficiency, Cirrhosis, Liver	100	France	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Assiut University	16	October 6, 2026
AstraZeneca	7	May 28, 2026
Northern Jiangsu People's Hospital	6	September 10, 2026
Institute of Liver and Biliary Sciences, India	6	March 12, 2026
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	5	June 5, 2026
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	4	October 28, 2026
Assistance Publique - Hôpitaux de Paris	4	July 27, 2026
Kafrelsheikh University	4	May 6, 2026
Beijing Continent Pharmaceutical Co, Ltd.	4	February 17, 2026
Tanta University	4	September 4, 2025
University Hospital Muenster	3	October 16, 2026
Nanfang Hospital, Southern Medical University	3	April 22, 2026
Hospices Civils de Lyon	3	December 8, 2025
Sohag University	3	August 11, 2025
Qilu Hospital of Shandong University	2	October 21, 2026
Regeneron Pharmaceuticals	2	October 2, 2026
The First Affiliated Hospital with Nanjing Medical University	2	October 1, 2026
Air Force Military Medical University, China	2	September 2, 2026
Siriraj Hospital	2	June 30, 2026
Shengjing Hospital	2	May 29, 2026

By phase

Phase	New trials	Latest
Observational	102	November 6, 2026
Not applicable	57	November 6, 2026
Phase 1	12	September 1, 2026
Phase 4	11	September 21, 2026
Phase 2	8	July 2, 2026
Phase 3	5	October 2, 2026
Phase 1/2	3	July 15, 2026
Phase 2/3	2	August 10, 2026

By country

Country	New trials	Latest
China	43	November 6, 2026
United States	20	October 2, 2026
Egypt	18	August 28, 2026
France	14	July 27, 2026
Italy	11	October 16, 2026
India	9	July 20, 2026
United Kingdom	8	June 8, 2026
Germany	7	October 16, 2026
Belgium	6	October 16, 2026
Spain	5	June 22, 2026
Pakistan	4	October 29, 2026
Austria	4	May 20, 2026
Netherlands	4	May 14, 2026
South Korea	3	November 6, 2026
Canada	3	October 21, 2026
Turkey (Türkiye)	3	September 28, 2026
Indonesia	3	September 1, 2026
Switzerland	3	July 15, 2026
Greece	3	June 22, 2026
Taiwan	3	June 18, 2026
Puerto Rico	3	June 8, 2026
Sweden	3	May 14, 2026
Thailand	2	June 30, 2026
Uganda	1	August 10, 2026
Japan	1	July 2, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.